ESC Professional Premium Access

Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

Event: ESC Congress 2022
Topic: Aortic Valve Intervention
Session type: Abstract Sessions
Date: 27 August 2022
Time: 15:30 - 16:30

Congress Session

6 presentations in this session

Trends in outcomes, complications and readmission rates in patients undergoing transcatheter aortic valve implantation: a nationwide analysis from 2012 to 2019

Speaker: Doctor A. Goel (Valhalla, US)
Thumbnail

Hospital procedural volume and clinical outcomes for transcatheter aortic valve replacement - US nationwide readmission database, 2016-2019.

Speaker: Doctor O. Al-Taweel (Las Vegas, US)
Thumbnail

Prevalence and prognostic impact of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. AMY-TAVI study.

Speaker: Doctor D. Lopez Otero (Santiago de Compostela, ES)
Thumbnail

Impact of periprocedural pulmonary hypertension on outcomes after TAVR: novel risk stratification from the OCEAN-TAVI Registry

Speaker: Doctor J. Miyamoto (Kanagawa, JP)
Thumbnail

Bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve replacement: multicenter propensity matched analysis

Speaker: Doctor G. Bonnet (Paris, FR)
Thumbnail

Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

Speaker: Doctor P. Guedeney (Paris, FR)
Thumbnail

6 speakers from this session

Doctor Akshay Goel

Westchester Medical Center, Valhalla (United States of America)
0 follower

Doctor Omar Al-Taweel

University of Nevada, Las Vegas School of Medicine, Las Vegas (United States of America)
0 follower

Doctor Diego Lopez Otero

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
0 follower

Doctor Junichi Miyamoto

Tokai University School of Medicine, Kanagawa (Japan)
0 follower

Doctor Guillaume Bonnet

Hopital Haut Leveque, Paris (France)
0 follower

Doctor Paul Guedeney

Pitie Salpetriere APHP University Hospital, Paris (France)
0 follower

This platform is supported by

logo Novo Nordisk